Literature DB >> 1689964

cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts.

L Vittone1, C Mundiña, G Chiappe de Cingolani, A Mattiazzi.   

Abstract

The present work was undertaken with two main goals: 1) to further elucidate the physiological role of the adenosine 3',5'-cyclic monophosphate (cAMP) and Ca2(+)-calmodulin (Ca2(+)-Cm)-dependent mechanisms of phospholamban phosphorylation (32PiPHL), and 2) to study the possible interaction between these two systems in the intact heart. Interventions that increased twitch or tetanic tension without modifying cAMP levels [high extracellular Ca2+ concentration [( Ca2+]o) or BAY K 8644 in catecholamine-depleted hearts] failed to alter 32PiPHL. Moderate and high beta-adrenergic stimulation (3 x 10(-9) and 3 x 10(-8) M isoproterenol, respectively) increased cAMP from 0.345 +/- 0.032 to 0.636 +/- 0.069 and 0.772 +/- 0.060 pmol/mg wet wt, and 32PiPHL from 26.8 +/- 4.1 to 58.6 +/- 13.1 and 174.7 +/- 13.8 pmol 32Pi/mg sarcoplasmic reticular [SR] protein, respectively. Both doses of isoproterenol produced an enhanced myocardial relaxation. Reversal of the positive inotropic effect of isoproterenol by interventions that decrease intracellular Ca2+ supply failed to reduce the enhancement in 32PiPHL and myocardial relaxation elicited by 3 x 10(-9) M isoproterenol but diminished the increase in 32PiPHL induced by 3 x 10(-8) M isoproterenol to 116.3 +/- 10.9 without significant changes in cAMP. Changes in myocardial relaxation closely paralleled the changes in 32PiPHL. These results suggest that 1) 32PiPHL may be enhanced by the cAMP-dependent mechanism independently of the Ca2(+)-Cm system, and 2) 32PiPHL and myocardial relaxation may be modified by intracellular Ca2+ changes only at high-intracellular cAMP levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689964     DOI: 10.1152/ajpheart.1990.258.2.H318

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation.

Authors:  Carlos A Valverde; Cecilia Mundiña-Weilenmann; Matilde Said; Paola Ferrero; Leticia Vittone; Margarita Salas; Julieta Palomeque; Martín Vila Petroff; Alicia Mattiazzi
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

2.  Role of Ca(2+)-calmodulin dependent phospholamban phosphorylation on the relaxant effect of beta-adrenergic agonists.

Authors:  L Vittone; C Mundiña; G Chiappe de Cingolani; A Mattiazzi
Journal:  Mol Cell Biochem       Date:  1993-07-07       Impact factor: 3.396

3.  Lusitropic effects of alpha- and beta-adrenergic stimulation in amphibian heart.

Authors:  M V Petroff; C Mundiña-Weilenmann; L Vittone; G Chiappe de Cingolani; A Mattiazzi
Journal:  Mol Cell Biochem       Date:  1994-12-21       Impact factor: 3.396

4.  Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.

Authors:  Cecilia Mundiña-Weilenmann; Matilde Said; Leticia Vittone; Paola Ferrero; Alicia Mattiazzi
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 5.  Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.

Authors:  P V Sulakhe; X T Vo
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

6.  Ca2+/calmodulin kinase II increases ryanodine binding and Ca2+-induced sarcoplasmic reticulum Ca2+ release kinetics during beta-adrenergic stimulation.

Authors:  Paola Ferrero; Matilde Said; Gina Sánchez; Leticia Vittone; Carlos Valverde; Paulina Donoso; Alicia Mattiazzi; Cecilia Mundiña-Weilenmann
Journal:  J Mol Cell Cardiol       Date:  2007-06-06       Impact factor: 5.000

Review 7.  Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase.

Authors:  Poornima Bhupathy; Gopal J Babu; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2007-03-12       Impact factor: 5.000

Review 8.  The role of CaMKII regulation of phospholamban activity in heart disease.

Authors:  Alicia Mattiazzi; Evangelia G Kranias
Journal:  Front Pharmacol       Date:  2014-01-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.